院外心脏骤停后48小时与24小时目标温度管理对神经功能结局的影响:一项随机临床试验
这项国际多中心随机优效性试验纳入355例院外心脏骤停后昏迷的成人患者,比较33°C目标温度管理48小时与24小时对6个月神经功能结局的影响。48小时组6个月良好神经功能结局为69%(120/175),24小时组为64%(112/176),差异无统计学显著性(RR 1.08,95%CI 0.93-1.25,P=0.33);48小时组不良事件更常见(97% vs 91%,P=0.04)。作者认为48小时并未显著改善6个月神经功能结局,但研究把握度可能有限,可能需进一步研究。
要点
- 在院外心脏骤停后昏迷患者中,33°C目标温度管理48小时较24小时未显著改善6个月良好神经功能结局。
- 48小时组6个月良好神经功能结局69%(120/175),24小时组64%(112/176),RR 1.08(95%CI 0.93-1.25),P=0.33。
- 48小时组不良事件更常见(97% vs 91%,RR 1.06,95%CI 1.01-1.12,P=0.04),ICU住院时间中位数更长(151 vs 117小时,P<0.001)。
核心结论
- 在收入ICU的院外心脏骤停后昏迷幸存者中,33°C目标温度管理48小时与24小时相比未显著改善6个月神经功能结局。
- 作者指出研究检测临床重要差异的把握度可能有限,可能需进一步研究。
研究设计与样本
- 国际、研究者发起、结局评估者盲法、平行、实用性、多中心、随机临床优效性试验,在6个欧洲国家10所大学医院的10个ICU进行。
- 2013年2月16日至2016年6月1日纳入355例院外心脏骤停后昏迷的成人患者,最终随访至2016年12月27日;随机分为48小时组(n=176)和24小时组(n=179),351例(99%)完成试验。
- 干预为33±1°C目标温度管理48小时或24小时,随后以每小时0.5°C逐渐复温至37°C。
主要发现
- 48小时组6个月良好神经功能结局(CPC评分1或2)为69%(120/175),24小时组为64%(112/176),差异4.9%(95%CI -5%至14.8%),RR 1.08(95%CI 0.93-1.25),P=0.33。
- 48小时组6个月死亡率为27%(48/175),24小时组为34%(60/177),差异-6.5%(95%CI -16.1%至3.1%),RR 0.81(95%CI 0.59-1.11),P=0.19。
- 48小时组与24小时组至死亡时间的风险比为0.79(95%CI 0.54-1.15),P=0.22。
- 48小时组不良事件发生率为97%,24小时组为91%,差异5.6%(95%CI 0.6%-10.6%),RR 1.06(95%CI 1.01-1.12),P=0.04。
- 48小时组ICU住院时间中位数为151小时,24小时组为117小时(P<0.001);住院时间中位数分别为11天与12天(P=0.50)。
关键数值与推荐
- 主要结局为6个月神经功能结局,以CPC评分1或2定义良好结局。
- 国际复苏指南推荐对院外心脏骤停后昏迷患者采用33°C至36°C目标温度管理至少24小时,但最佳持续时间不确定。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者指出研究检测临床重要差异的把握度可能有限。
- 作者指出可能需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: International resuscitation guidelines recommend targeted temperature management (TTM) at 33°C to 36°C in unconscious patients with out-of-hospital cardiac arrest for at least 24 hours, but the optimal duration of TTM is uncertain. OBJECTIVE: To determine whether TTM at 33°C for 48 hours results in better neurologic outcomes compared with currently recommended, standard, 24-hour TTM. DESIGN, SETTING, AND PARTICIPANTS: This was an international, investigator-initiated, blinded-outcome-assessor, parallel, pragmatic, multicenter, randomized clinical superiority trial in 10 intensive care units (ICUs) at 10 university hospitals in 6 European countries. Three hundred fifty-five adult, unconscious patients with out-of-hospital cardiac arrest were enrolled from February 16, 2013, to June 1, 2016, with final follow-up on December 27, 2016. INTERVENTIONS: Patients were randomized to TTM (33 ± 1°C) for 48 hours (n = 176) or 24 hours (n = 179), followed by gradual rewarming of 0.5°C per hour until reaching 37°C. MAIN OUTCOMES AND MEASURES: The primary outcome was 6-month neurologic outcome, with a Cerebral Performance Categories (CPC) score of 1 or 2 used to define favorable outcome. Secondary outcomes included 6-month mortality, including time to death, the occurrence of adverse events, and intensive care unit resource use. RESULTS: In 355 patients who were randomized (mean age, 60 years; 295 [83%] men), 351 (99%) completed the trial. Of these patients, 69% (120/175) in the 48-hour group had a favorable outcome at 6 months compared with 64% (112/176) in the 24-hour group (difference, 4.9%; 95% CI, -5% to 14.8%; relative risk [RR], 1.08; 95% CI, 0.93-1.25; P = .33). Six-month mortality was 27% (48/175) in the 48-hour group and 34% (60/177) in the 24-hour group (difference, -6.5%; 95% CI, -16.1% to 3.1%; RR, 0.81; 95% CI, 0.59-1.11; P = .19). There was no significant difference in the time to mortality between the 48-hour group and the 24-hour group (hazard ratio, 0.79; 95% CI, 0.54-1.15; P = .22). Adverse events were more common in the 48-hour group (97%) than in the 24-hour group (91%) (difference, 5.6%; 95% CI, 0.6%-10.6%; RR, 1.06; 95% CI, 1.01-1.12; P = .04). The median length of intensive care unit stay (151 vs 117 hours; P < .001), but not hospital stay (11 vs 12 days; P = .50), was longer in the 48-hour group than in the 24-hour group. CONCLUSIONS AND RELEVANCE: In unconscious survivors from out-of-hospital cardiac arrest admitted to the ICU, targeted temperature management at 33°C for 48 hours did not significantly improve 6-month neurologic outcome compared with targeted temperature management at 33°C for 24 hours. However, the study may have had limited power to detect clinically important differences, and further research may be warranted. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01689077.
引用
- Kirkegaard H, Søreide E, de Haas I, et al. Targeted Temperature Management for 48 vs 24 Hours and Neurologic Outcome After Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial. JAMA. 2017. PMID: 28742911. doi:10.1001/jama.2017.8978
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。